Completion of biodistribution study

  • 10:41

Immunicum successfully completes a biodistribution study of its cancer vaccine injected into kidneys in rats as a final step towards receiving an approval from the Medical Products Agency (MPA) to initiate its first clinical trial. Applications to initiate the clinical trial will be handed in to the MPA shortly.